» Articles » PMID: 23601648

Analysis of Chemical and Biological Features Yields Mechanistic Insights into Drug Side Effects

Overview
Journal Chem Biol
Publisher Elsevier
Date 2013 Apr 23
PMID 23601648
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Side effects (SEs) are the unintended consequence of therapeutic treatments, but they can also be seen as valuable readouts of drug effects, resulting from the perturbation of biological systems by chemical compounds. Unfortunately, biology and chemistry are often considered separately, leading to incomplete models unable to provide a unified view of SEs. Here, we investigate the molecular bases of over 1,600 SEs by navigating both chemical and biological spaces. We identified characteristic molecular traits for 1,162 SEs, 38% of which can be explained using solely biological arguments, and only 6% are exclusively associated with the chemistry of the compounds, implying that the drug action is somewhat unspecific. Overall, we provide mechanistic insights for most SEs and emphasize the need to blend biology and chemistry to surpass intricate phenomena not captured in the molecular biology view.

Citing Articles

Machine Learning Techniques for Predicting Drug-Related Side Effects: A Scoping Review.

Toni E, Ayatollahi H, Abbaszadeh R, Fotuhi Siahpirani A Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931462 PMC: 11206653. DOI: 10.3390/ph17060795.


Insights into Drug Cardiotoxicity from Biological and Chemical Data: The First Public Classifiers for FDA Drug-Induced Cardiotoxicity Rank.

Seal S, Spjuth O, Hosseini-Gerami L, Garcia-Ortegon M, Singh S, Bender A J Chem Inf Model. 2024; 64(4):1172-1186.

PMID: 38300851 PMC: 10900289. DOI: 10.1021/acs.jcim.3c01834.


Insights into Drug Cardiotoxicity from Biological and Chemical Data: The First Public Classifiers for FDA DICTrank.

Seal S, Spjuth O, Hosseini-Gerami L, Garcia-Ortegon M, Singh S, Bender A bioRxiv. 2023; .

PMID: 37905146 PMC: 10614794. DOI: 10.1101/2023.10.15.562398.


A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs.

Sutherland J, Yonchev D, Fekete A, Urban L Nat Commun. 2023; 14(1):4323.

PMID: 37468498 PMC: 10356841. DOI: 10.1038/s41467-023-40064-9.


Rituximab and Pyoderma Gangrenosum: An Investigation of Disproportionality Using a Systems Biology-Informed Approach in the FAERS Database.

Hillen J, Stanford T, Ward M, Roughead E, Kalisch Ellett L, Pratt N Drugs Real World Outcomes. 2022; 9(4):639-647.

PMID: 35933497 PMC: 9712896. DOI: 10.1007/s40801-022-00322-6.